APA (7th ed.) Citation

JX, Z., LB, G., CS, Z., QZ, H., ZS, L., MM, W., . . . YY, Z. (2025). Time to recurrence and BCLC stage at recurrence as critical variables in guiding treatment decisions for early-recurrent hepatocellular carcinoma after liver resection. Frontiers in oncology, 15, 1672696. https://doi.org/10.3389/fonc.2025.1672696

Chicago Style (17th ed.) Citation

JX, Zhang, et al. "Time to Recurrence and BCLC Stage at Recurrence as Critical Variables in Guiding Treatment Decisions for Early-recurrent Hepatocellular Carcinoma After Liver Resection." Frontiers in Oncology 15 (2025): 1672696. https://doi.org/10.3389/fonc.2025.1672696.

MLA (9th ed.) Citation

JX, Zhang, et al. "Time to Recurrence and BCLC Stage at Recurrence as Critical Variables in Guiding Treatment Decisions for Early-recurrent Hepatocellular Carcinoma After Liver Resection." Frontiers in Oncology, vol. 15, 2025, p. 1672696, https://doi.org/10.3389/fonc.2025.1672696.